Blood cancers, Non-Hodgkin lymphoma (NHL)
Open
Phase 1/2
This trial is looking at a new type of targeted cancer drug called ALETA-001.
It is for people with B cell after CAR T-cell therapy targeting the CD19 protein.
Cancer Research UK supports this trial.
Recruitment start: 20 December 2023
Recruitment end: 28 February 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sridhar Chaganti
Cancer Research UK
This is Cancer Research UK trial number CRUKD/23/001.
Last reviewed: 22 April 2025
CRUK internal database number: 19874
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
